These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

963 related items for PubMed ID: 24022433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S.
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X, Yu L, Wang L, Wang J, Wu Y, Chen Z, Zhu H.
    Int J Cancer; 2015 Jan 01; 136(1):152-61. PubMed ID: 23456911
    [Abstract] [Full Text] [Related]

  • 5. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
    Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJ, Yu J.
    Clin Cancer Res; 2014 Jun 01; 20(11):2994-3002. PubMed ID: 24691020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X, Wu Y, Ji M, Zhang S.
    Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY, Chen CC, Chang YS, Tsai WS, You JF, Lin GP, Chen TW, Chen JS, Chan EC.
    Oncotarget; 2016 Mar 01; 7(9):10663-75. PubMed ID: 26848774
    [Abstract] [Full Text] [Related]

  • 12. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
    Giráldez MD, Lozano JJ, Ramírez G, Hijona E, Bujanda L, Castells A, Gironella M.
    Clin Gastroenterol Hepatol; 2013 Jun 01; 11(6):681-8.e3. PubMed ID: 23267864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 15. miR-194 as a predictor for adenoma recurrence in patients with advanced colorectal adenoma after polypectomy.
    Wang ZH, Ren LL, Zheng P, Zheng HM, Yu YN, Wang JL, Lin YW, Chen YX, Ge ZZ, Chen XY, Hong J, Fang JY.
    Cancer Prev Res (Phila); 2014 Jun 01; 7(6):607-16. PubMed ID: 24691499
    [Abstract] [Full Text] [Related]

  • 16. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY, Zhao XJ, Yu ZF, Hu FL, Liu YP, Cui BB, Dong XS, Zhao YS.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(6):7092-101. PubMed ID: 26261602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.
    PLoS One; 2012 Jun 01; 7(9):e44398. PubMed ID: 22970209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.